Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
Conditions: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent Intervention: Drug: rifapentine plus isoniazid Sponsors: Huashan Hospital; Shanghai First Maternity and Infant Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2020 Category: Research Source Type: clinical trials
A Cross-sectional Study to Estimate the Influence of Malnutrition, Diabetes Mellitus and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
Conditions: Mycobacterium Tuberculosis; LTBI (Latent TB Infection); Malnutrition; Diabetes Mellitus; Helminth Infections Intervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2020 Category: Research Source Type: clinical trials
The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
Conditions: Mycobacterium Tuberculosis; LTBI (Latent TB Infection); Malnutrition; Diabetes Mellitus; Helminth Infections Intervention: Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2020 Category: Research Source Type: clinical trials
Phenotyping of High Dose Rifampicin
Condition: Tuberculosis Intervention: Drug: rifampicin Sponsor: Radboud University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2020 Category: Research Source Type: clinical trials
Kharituwe TB Contact Tracing Study
Conditions: Tuberculosis; Hiv Intervention: Behavioral: Household contact tracing Sponsors: Johns Hopkins Bloomberg School of Public Health; Perinatal HIV Research Unit of the University of the Witswatersrand; Setshaba Research Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2020 Category: Research Source Type: clinical trials
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
Conditions: HIV Infections; Tuberculosis Interventions: Drug: Bictegravir (BIC); Drug: Tenofovir alafenamide (TAF); Drug: Cabotegravir (CAB); Drug: Dolutegravir (DTG); Drug: Atazanavir/ritonavir (ATV/r); Drug: Darunavir/ritonavir (DRV/r); Drug: Lopinavir/ritonavir (LPV/r); Drug: Cobicistat; Drug: Ritonavir; Drug: First-Line TB Treatment; Drug: Second-Line TB Treatment; Drug: Doravirine (DOR) Sponsor...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials
Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients
Conditions: HIV Infections; Tuberculosis Interventions: Drug: Efavirenz 600mg; Drug: Efavirenz 400mg Sponsor: Shanghai Public Health Clinical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2020 Category: Research Source Type: clinical trials
